Coverage
-
June 10, 2022
An investor in the medical technology company Arrayit Corp. pleaded guilty to securities fraud in California federal court Thursday, admitting his role in a scheme to manipulate the prices of its stock through the spread of false and misleading information about the company, according to hearing minutes.
1 other articles on this case.
View all »